November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Vérane Achard: Our editorial on the long-term results of the RTOG 0712
Nov 1, 2024, 08:06

Vérane Achard: Our editorial on the long-term results of the RTOG 0712

Vérane Achard, Radiation Oncologist and Chief Clinical Director at Fribourg Cantonal Hospital, shared a post on X about her recent paper published in the International Journal of Radiation Oncology Biology Physics:

“Honored to share this editorial with Robert Huddart, covering the long-term results of the RTOG 0712. While we wait for a miracle molecule that could eliminate the need for any local ttt, CRT therapy remains the only bladder preservation treatment for MIBC.”

Chemoradiation therapy for Nonmetastatic Muscle-Invasive Bladder Cancer: Still the Only Bladder Preservation Treatment in 2024″

Authors: Vérane Achard and Robert Huddart.

Vérane Achard: Our editorial on the long-term results of the RTOG 0712

Vérane Achard is a Radiation Oncologist and Chief Clinical Director at Fribourg Cantonal Hospital. She holds a PhD in Physics, an MSc in Engineering and is a Private Lecturer at the University of Geneva. Dr. Achard also serves as the representative of GU Young and Early Career Investigators at the European Organisation for Research and Treatment of Cancer (EORTC).